SCHEMBL14822784

SCHEMBL14822784

CC(=O)Nc1ccc(C)cc1C(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
HSD17B10 Q99714 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.49
GFER P55789 1/20 0.49
ALDH1A1 P00352 4/20 0.49
ALOX15 P16050 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
HPGD P15428 3/20 0.47
POLB P06746 3/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C19 P33261 2/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001348 0.87 KDM4E (0.67) KMT2AHSD17B10KDM4EMEN1GFER
SCHEMBL14191236 0.82 PRKCI (0.46) KMT2AHSD17B10KDM4EMEN1GFER
SCHEMBL405878 0.81 HDAC1 (0.65) KMT2AHSD17B10KDM4EMEN1ALDH1A1
SCHEMBL27704672 0.81 ALDH1A1 (0.53) KMT2AHSD17B10KDM4EMEN1ALDH1A1
SCHEMBL2306741 0.80 KMT2A (0.69) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL18131322 0.80 TDP1 (0.52) KMT2AHSD17B10KDM4EMEN1ALDH1A1
SCHEMBL14884639 0.80 MEN1 (0.68) KMT2AKDM4EMEN1GFERALDH1A1
SCHEMBL15014104 0.79 RAB9A (0.49) HSD17B10KDM4EALDH1A1ALOX15POLB
SCHEMBL9469411 0.79 KDM4E (0.77) HSD17B10KDM4EALDH1A1ALOX15POLB
SCHEMBL796957 0.79 ALDH1A1 (0.73) KMT2AHSD17B10KDM4EMEN1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410155-B2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-02 US disclosed